Abstract
The objectives of this cross-sectional analysis were to determine healthcare resource utilization and cost for community-dwelling patients with dementia (PWD) from a payer’s and societal perspective, and to analyze the associations between costs and sociodemographic and clinical variables. Analysis of healthcare costs from a payer’s perspective was based on a sample of 425 PWD, analysis of healthcare costs from societal perspective on a subsample of 254 PWD and their informal caregivers. Frequency of healthcare resource utilization was assessed by means of questionnaires. Informal care and productivity losses were assessed by using the Resource Utilization in Dementia questionnaire (RUD). Costs were monetarized using standardized unit costs. To analyze the associations, multiple linear regression models were used. Total annual costs per PWD valued 7016€ from a payer’s and 25,877€ from a societal perspective, meaning that societal cost is approximately three and a half times as much as payer’s expenditures. Costs valuated 5456 € for medical treatments, 1559 € for formal care, 18,327€ for informal care. Productivity losses valued 1297€ for PWD caregivers. Informal care could vary substantially (−21%; +33%) concerning different valuation methods. Medical care costs decreased significantly with progression of dementia and with age. Costs of care double over the stages of dementia. Formal care costs were significantly higher for PWD living alone and informal care costs significantly lower for PWD with an employed caregiver. For all cost categories, deficits in daily living activities were major cost drivers.
Similar content being viewed by others
Notes
Exchange rate: 1€ = $1.06763 (November 2015).
References
Fendrich, K., Hoffmann, W.: More than just aging societies: the demographic change has an impact on actual numbers of patients. J Public Health 15(5), 345–351 (2007)
Prince, M., Wimo, A., Guerchet, M., Ali, G-C., Wu, Y-T., Prina, M.: World Alzheimer Report 2015. The Global Impact of Dementia. An analysis of prevalence, incidence, costs and trends. World Alzheimer Report. London, Alzheimer´s Diseases International. (2015)
Alzheimer’s Disease International (ADI): Dementia statistics. http://www.alz.co.uk/research/statistics (2015)
Grass-Kapanke, B., Kunczik, T., Gutzmann, H.: Studie zur Demenzversorgung im ambulanten Sektor-DIAS. In: vol. Demenzversorgung im ambulanten Sektor-DIAS. (2008)
Quentin, W., Riedel-Heller, S.G., Luppa, M., Rudolph, A., Konig, H.H.: Cost-of-illness studies of dementia: a systematic review focusing on stage dependency of costs. Acta Psychiatr Scand 121(4), 243–259 (2010)
Lopez-Bastida, J., Serrano-Aguilar, P., Perestelo-Perez, L., Oliva-Moreno, J.: Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain. Neurology 67(12), 2186–2191 (2006)
Boada, M., Pena-Casanova, J., Bermejo, F., Guillen, F., Hart, W.M., Espinosa, C., Rovira, J.: Costs of health care resources of ambulatory-care patients diagnosed with Alzheimer’s disease in Spain. Med Clin 113(18), 690–695 (1999)
Leon, J., Cheng, C.K., Neumann, P.J.: Alzheimer’s disease care: costs and potential savings. Health Aff 17(6), 206–216 (1998)
Leon, J., Neumann, P.J.: The cost of Alzheimer’s disease in managed care: a cross-sectional study. Am J Manag Care 5(7), 867–877 (1999)
Taylor Jr, D.H., Schenkman, M., Zhou, J., Sloan, F.A.: The relative effect of Alzheimer’s disease and related dementias, disability, and comorbidities on cost of care for elderly persons. J Gerontol Series B Psychol Sci Soc Sci 56(5), S285–293 (2001)
Rigaud, A.S., Fagnani, F., Bayle, C., Latour, F., Traykov, L., Forette, F.: Patients with Alzheimer’s disease living at home in France: costs and consequences of the disease. J Geriatr Psychiatry Neurol 16(3), 140–145 (2003)
Schwarzkopf, L., Menn, P., Kunz, S., Holle, R., Lauterberg, J., Marx, P., Mehlig, H., Wunder, S., Leidl, R., Donath, C., Graessel, E.: Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage. Value Health 14(6), 827–835 (2011)
König, H.H., Leicht, H., Brettschneider, C., Bachmann, C., Bickel, H., Fuchs, A., Jessen, F., Kohler, M., Luppa, M., Mosch, E., Pentzek, M., Werle, J., Weyerer, S., Wiese, B., Scherer, M., Maier, W., Riedel-Heller, S.G.: The costs of dementia from the societal perspective: is care provided in the community really cheaper than nursing home care? J Am Med Dir Assoc 15(2), 117–126 (2014)
van den Berg, B., Brouwer, W.B., Koopmanschap, M.A.: Economic valuation of informal care. An overview of methods and applications. Eur J Health Econ HEPAC Health Econ Prevent Care 5(1), 36–45 (2004)
Federal Statistical Office: Predicted change of the number of potential informal care givers and persons in need for care in the years from 2006 to 2050 in Germany (2008)
Leicht, H., Heinrich, S., Heider, D., Bachmann, C., Bickel, H., van den Bussche, H., Fuchs, A., Luppa, M., Maier, W., Mosch, E., Pentzek, M., Rieder-Heller, S.G., Tebarth, F., Werle, J., Weyerer, S., Wiese, B., Zimmermann, T., Konig, H.H., AgeCoDe Study Group: Net costs of dementia by disease stage. Acta Psychiatr Scand 124(5), 384–395 (2011)
Schwarzkopf, L., Menn, P., Leidl, R., Graessel, E., Holle, R.: Are community-living and institutionalized dementia patients cared for differently? Evidence on service utilization and costs of care from German insurance claims data. BMC Health Serv Res 13, 2 (2013)
Boustani, M., Peterson, B., Hanson, L., Harris, R., Lohr, K.N.: Force, U.S.P.S.T.: Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 138(11), 927–937 (2003)
Connolly, A., Gaehl, E., Martin, H., Morris, J., Purandare, N.: Underdiagnosis of dementia in primary care: variations in the observed prevalence and comparisons to the expected prevalence. Aging Ment Health 15(8), 978–984 (2011)
Eichler, T., Thyrian, J.R., Hertel, J., Kohler, L., Wucherer, D., Dreier, A., Michalowsky, B., Teipel, S., Hoffmann, W.: Rates of formal diagnosis in people screened positive for dementia in primary care: results of the DelpHi-Trial. J Alzheimer’s Dis JAD 42(2), 451–458 (2014)
Michalowsky, B., Eichler, T., Thyrian, J.R., Hertel, J., Wucherer, D., Hoffmann, W., Flessa, S.: Healthcare resource utilization and cost in dementia: are there differences between patients screened positive for dementia with and those without a formal diagnosis of dementia in primary care in Germany? Int Psychogeriatr 28(3), 359–369 (2016)
Reese, J.P., Hessmann, P., Seeberg, G., Henkel, D., Hirzmann, P., Rieke, J., Baum, E., Dannhoff, F., Muller, M.J., Jessen, F., Geldsetzer, M.B., Dodel, R.: Cost and care of patients with Alzheimer’s disease: clinical predictors in German health care settings. J Alzheimer’s Dis JAD 27(4), 723–736 (2011)
Thyrian, J.R., Fiss, T., Dreier, A., Bowing, G., Angelow, A., Lueke, S., Teipel, S., Flessa, S., Grabe, H.J., Freyberger, H.J., Hoffmann, W.: Life- and person-centred help in Mecklenburg-Western Pomerania, Germany (DelpHi): study protocol for a randomised controlled trial. Trials 13, 56 (2012)
Thyrian, J.R., Eichler, T., Michalowsky, B., Wucherer, D., Reimann, M., Hertel, J., Richter, S., Dreier, A., Hoffmann, W.: Community-Dwelling People Screened Positive for Dementia in Primary Care: A Comprehensive. Multivariate Descriptive Analysis Using Data from the DelpHi-Study, J Alzheimers Dis (2016)
Kalbe, E., Kessler, J., Calabrese, P., Smith, R., Passmore, A.P., Brand, M., Bullock, R.: DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 19(2), 136–143 (2004)
Michalowsky, B., Thyrian, J.R., Eichler, T., Hertel, J., Wucherer, D., Flessa, S., Hoffmann, W.: Economic analysis of formal care, informal care, and productivity losses in primary care patients who screened positive for dementia in Germany. J Alzheimers Dis 50(1), 47–59 (2015)
Wimo, A., Nordberg, G.: Validity and reliability of assessments of time. Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrument. Arch Gerontol Geriatr 44(1), 71–81 (2007)
Kessler, J., Markowitsch, H.J., Denzler, P.: Mini-Mental-Status-Test (MMST) [German Version]. Beltz Test GmbH, Göttingen (1990)
Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN): S3-Leitlinie “Demenzen”. Internet (2015)
Mackin, R.S., Ayalon, L., Feliciano, L., Arean, P.A.: The sensitivity and specificity of cognitive screening instruments to detect cognitive impairment in older adults with severe psychiatric illness. J Geriatr Psychiatry Neurol 23(2), 94–99 (2010)
Kohn, N., Kalbe, E., Georg, H., Kessler, J.: Vergleich MMST und DemTect: Spezifität und Sensitivität bei primär kognitiven Störungen. Akt Neurol 34 (2007)
Hindmarch, I., Lehfeld, H., de Jongh, P., Erzigkeit, H.: The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord 9(Suppl 2), 20–26 (1998)
Erzigkeit, H., Lehfeld, H., Pena-Casanova, J., Bieber, F., Yekrangi-Hartmann, C., Rupp, M., Rappard, F., Arnold, K., Hindmarch, I.: The Bayer-Activities of Daily Living Scale (B-ADL): results from a validation study in three European countries. Dement Geriatr Cogn Disord 12(5), 348–358 (2001)
Gauggel, S., Birkner, B.: Validity and reliability of a German version of the Geriatric Depression Scale (GDS). Zeitschrift für Klinische Psychologie-Forschung und Praxis 28(1), 18–27 (1999)
Byford, S., Torgerson, D.J., Raftery, J.: Economic note: cost of illness studies. BMJ 320(7245), 1335 (2000)
Federal Statistical Office: Verdienste und Arbeitskosten-Arbeitnehmerverdienste. Federal Statistical Office (2015)
Statistische Ämter des Bundes und der Länder: Preise- Verbraucherpreisindizies für Deutschland. Jahresbericht 2013. In: (2014)
Krauth, C., Hessel, F., Hansmeier, T., Wasem, J., Seitz, R., Schweikert, B.: Empirical standard costs for health economic evaluation in Germany–a proposal by the working group methods in health economic evaluation. Gesundheitswesen 67(10), 736–746 (2005)
Bock, J.O., Brettschneider, C., Seidl, H., Bowles, D., Holle, R., Greiner, W., Konig, H.H.: Calculation of standardised unit costs from a societal perspective for health economic evaluation. Gesundheitswesen 77(1), 53–61 (2015)
Statistisches Bundesamt: Gesundheit - Grunddaten der Krankenhäuser 2014. https://www.destatis.de/DE/Publikationen/Thematisch/Gesundheit/Krankenhaeuser/GrunddatenKrankenhaeuser2120611147004.pdf?__blob=publicationFile (2015)
Statistische Ämter des Bundes und der Länder: Kostennachweis der Krankenhäuser 2012. In: Fachserie 12 Reihe 6.3. (2013)
WIdO (Wissenschaftliches Institut der AOK): GKV-Arzneimittelindex. http://www.wido.de/gkv-arzneimittelind.html (2013)
WIdO (Wissenschaftliches Institut der AOK): Heilmittel- Einzelpreise in EURO nach Kassenart-Stand Mai 2014. In. (2014)
Statistische Ämter des Bundes und der Länder: Pflegestatistik 2013-Pflege im Rahmen der Pflegeversicherung. Deutschlandergebnisse In, Wiesbaden (2015)
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG): Arbeitspapier Kostenbestimmung. http://www.ifeg.de/cms/upload/pdf/SD253_GQ.pdf (2009)
Desgagne, A., Castilloux, A.M., Angers, J.F., LeLorier, J.: The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics 13(5 Pt 1), 487–497 (1998)
StataCorp: Stata Statistical Software: Release 13. In. College Station, TX: StataCorp LP, (2014)
Zhu, C.W., Cosentino, S., Ornstein, K., Gu, Y., Scarmeas, N., Andrews, H., Stern, Y.: Medicare utilization and expenditures around incident dementia in a multiethnic cohort. J Gerontol Series A Biol Sci Med Sci 70(11), 1448–1453 (2015)
Schulnburg, J., Schulenburg, I., Horn, R.: Cost of treatment and care of Alzheimer´s disease in Germany. In: Wimo, A.S.S.S., Jönsson, B., Karlsson, G., Winblad, B. (eds.) Health economics of dementia. Wiley, Chichester (1998)
Ducharme, F., Levesque, L., Lachance, L., Kergoat, M.J., Coulombe, R.: Challenges associated with transition to caregiver role following diagnostic disclosure of Alzheimer disease: a descriptive study. Int J Nurs Stud 48(9), 1109–1119 (2011)
Leicht, H., Konig, H.H., Stuhldreher, N., Bachmann, C., Bickel, H., Fuchs, A., Heser, K., Jessen, F., Kohler, M., Luppa, M., Mosch, E., Pentzek, M., Riedel-Heller, S., Scherer, M., Werle, J., Weyerer, S., Wiese, B., Maier, W., AgeCoDe Study Group: Predictors of costs in dementia in a longitudinal perspective. PLoS One 8(7), e70018 (2013)
Joling, K.J., Schope, J., van Hout, H.P., van Marwijk, H.W., van der Horst, H.E., Bosmans, J.E.: Predictors of Societal Costs in Dementia Patients and Their Informal Caregivers: A Two-Year Prospective Cohort Study. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry 23(11), 1193–1203 (2015)
Bergmann, K., Foster, E.M., Justice, A.W., Matthews, V.: Management of the demented elderly patient in the community. Br J Psychiatry 132, 441–449 (1978)
Statistische Ämter des Bundes und der Länder: Demografischer Wandel in Deutschland-Auswirkungen auf Krankenhausbehandlungen und Pflegebedürftige im Bund und in den Ländern. In: Länder, S.Ä.d.B.u.d. (ed.) Demografischer Wandel in Deutschland. pp. 2–34. Wiesbaden (2008)
Tarricone, R.: Cost-of-illness analysis. What room in health economics? Health Policy 77(1), 51–63 (2006)
Acknowledgements
Development, co-ordination, and implementation of the DelpHi-MV trial was influenced by input from several experts in their respective field and supported by an experienced field study team: Ines Abraham, Grit Aßmann, Kerstin Albuerne, Vaska Böhmann, Georgia Böwing, Kathleen Dittmer, Thomas Fiß, Sarah Gardzella, Jana Hubert, Ulrike Kempe, Ingo Kiliman, Leonore Köhler, Saskia Moll, Andrea Pooch, Sabine Schmidt, Christiane Schnick, Stefan Teipel, and Christine Winckler.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Michalowsky, B., Flessa, S., Eichler, T. et al. Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial. Eur J Health Econ 19, 87–102 (2018). https://doi.org/10.1007/s10198-017-0869-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-017-0869-7